Type : Bid Notification
This is due to the fact that Cambridge Isotope Laboratories has been providing all of the Deuterium oxide 70% for use this study. The NIA Clinical unit must continue to use isotopes from Cambridge Isotopes to maintain scientific integrity. To use isotopes from another company would invalidate all research data that has been collected thus far.